Egetis Therapeutics AB (publ)
556706-6724ActiveInnovative pharmaceutical company developing late-stage orphan drug treatments.
Översikt
- 20–49
- Anställda
- 100–500milj SEK
- Omsättning
- 2006
- Grundat
Nyckelbeslutsfattare
Yilmaz Mahshid
Chief Financial Officer
Karl Hård
Vice President, Head of Investor Relations and Business Development
Nicklas Westerholm
Chief Executive Officer
Anny Bedard
President Egetis North America
+16 fler kontakter i Funnelfeedr
Beskrivning
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on bringing novel treatments to market. The organization concentrates its efforts on projects in late-stage development, aiming for commercialization of specialized therapies. Their primary focus lies within the orpha...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556706672401
Beslutsfattare
20 kontakter i FunnelfeedrYilmaz Mahshid
Chief Financial Officer
Karl Hård
Vice President, Head of Investor Relations and Business Development
Nicklas Westerholm
Chief Executive Officer
Anny Bedard
President Egetis North America
Christian Sonesson
Vice President Product Strategy & Development
Gunilla Osswald
Board Member
Tiago Nunes
Chief Medical Officer
Laetitia Szaller
General Counsel & Head of Compliance
Nils Hallén
Global Head of HR
Elisabeth Svanberg
Board Member
Margarida Duarte
Board Member
Sofie Broberg
Vice President Regulatory Affairs
Katayoun Welin-Berger
Vice President Technical Operations
Birgitte Volck
Board Member
Henrik Krook
Vice President Commercial Operations
Mats Blom
Chairman of the Board
Behshad Sheldon
Board Member
Katayoun (Katy) Welin-Berger
Vice President Operations
Jay Donovan Wu
Board Member
Kristina Sjöblom Nygren
Chief Medical Officer
Liknande företag
20 liknande företag i FunnelfeedrPTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
AMICUS THERAPEUTICS LTD
1–4 anställdaGlobal biotechnology company developing transformative medicines for rare diseases.
Swedish Orphan Biovitrum AB (publ)
200–499 anställdaGlobal biopharma unlocking breakthrough therapies for rare diseases.
Alnylam Sweden AB
5–9 anställdaLeading RNAi therapeutics company developing gene-silencing medicines.
NORGINE HEALTHCARE B.V.
0 anställdaLeading European specialist pharmaceutical company acquiring and commercializing medicines.
Utforska mer
Frågor om Egetis Therapeutics AB (publ)
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo